Segmentation of Treatment Modalities: Comparing the Market Performance of Pharmaceutical, Ablation, and Device-Based Therapies in the UK Tachycardia Market
  The UK Tachycardia Market is primarily organized into three major treatment segments: Pharmaceuticals, Catheter Ablation, and Implantable Devices (Pacemakers/ICDs). The Pharmaceutical segment, comprising antiarrhythmic drugs and beta-blockers, continues to dominate the market by volume and initial prescription rate, driven by the sheer number of patients who receive drug therapy as a...
0 Comments 0 Shares 48 Views 0 Reviews